![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 22, 99917, June 2, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Congenital hyperinsulinism (HI) is a group of disorders that cause hypoglycemia in infants and children. The majority of these cases appears to be due to genetic defects in the regulation of insulin secretion by pancreatic
-cells. For example, children with mutations in glutamate dehydrogenase (GDH) experience a hyperinsulinism-hyperammonemia syndrome (GDH-HI), and their
-cells are sensitized to leucine stimulation.
To increase understanding of the role of GDH in insulin secretion, Changhong Li and colleagues generated GDH transgenic mice that expressed in islets the mutant human GDH-HI H454Y and human wild-type GDH with the rat insulin promoter. The H454Y GDH transgenic mice had hypoglycemia, confirming that the H454Y mutation can cause disease. Enhancement of insulin release by the H454Y GDH mutation or by leucine activation was associated with increased oxidative deamination of glutamate via GDH. These results confirm that in mouse islets GDH functions predominantly in the direction of glutamate oxidation rather than glutamate synthesis, and this flux is tightly controlled by glucose.
FOOTNOTES
See referenced article, J. Biol. Chem. 2006, 281, 1506415072 ![]()
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |